Niti Aayog Member Vk Paul
- All
- News
- Videos
-
"Don't Panic But Be A Little Vigilant": NITI Aayog As Covid Cases Rise
NITI Aayog member Dr VK Paul on Wednesday asked fellow citizens not to panic about the new COVID-19 variant JN.1 and assured them that the Centre is taking the necessary precautions to combat the new variant.
-
No Need To Panic: NITI Aayog member VK Paul On Monkeypox
Four cases of monkeypox have been reported in India but there is absolutely no need for any panic as the government has taken significant measures to keep the disease in check, said Niti Aayog member Dr VK Paul.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
Serosurvey Does Not Cover Granularity At State Level: NITI Aayog Member
Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.
-
"Be Watchful, Next 3 Months Important": NITI Aayog Member's Advice To Delhi
Niti Aayog member V K Paul has told the Delhi government to remain watchful as the next three months are important and unlocking activities can lead to an increase in coronavirus cases.
-
India Has Been Offered 7.5 Million Doses Of Moderna COVID-19 Vaccine Through COVAX: WHO
The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
-
Second Wave Not Over, No One Safe Till Entire Country Is Safe: NITI Aayog Member
VK Paul said that the second wave of COVID-19 is not over yet even though India is seeing a decline in the number of fresh cases.
-
"In A Marathon, Not A 100-Metre Sprinter": Centre On Covid Vaccination
India is vaccinating, on average, 50 lakh individuals against Covid daily since June 21, the Centre said today. The number has increased since the drive's new phase phase kicked in on June 21, said Dr VK Paul, NITI Aayog member for health.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Manufacturers To Decide Price Of Covid Vaccines To Private Sectors: Niti Aayog
The price of COVID-19 vaccines to private sectors (hospitals) will be decided by vaccine manufacturers, informed Member (health) NITI Aayog Dr VK Paul on Tuesday.
-
India Overtakes US, Has More Number Of People With 1st Dose Of Vaccine
Member Health NITI Aayog Dr VK Paul on Friday said India has overtaken the United States in terms of the number of people who have received the first dose of COVID-19 vaccine.
-
Pfizer's Indemnity Request Being Examined, Supply Likely In July: Centre
The government is examining Pfizer's request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) VK Paul said today.
-
Must Prepare To Administer One Crore Vaccine Doses Per Day: NITI Aayog
India should prepare to administer one crore Covid jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 lakh doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul said.
-
"Don't Panic But Be A Little Vigilant": NITI Aayog As Covid Cases Rise
NITI Aayog member Dr VK Paul on Wednesday asked fellow citizens not to panic about the new COVID-19 variant JN.1 and assured them that the Centre is taking the necessary precautions to combat the new variant.
-
No Need To Panic: NITI Aayog member VK Paul On Monkeypox
Four cases of monkeypox have been reported in India but there is absolutely no need for any panic as the government has taken significant measures to keep the disease in check, said Niti Aayog member Dr VK Paul.
-
Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog
The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.
-
Masks Will Stay Through 2022, Need Drug Against Covid: NITI Aayog Member
Dr VK Paul, the NITI Aayog Member for Health, said battling Covid will require a combination of vaccines, effective drugs, and disciplined social behaviour. He did not ruling out a third wave and cautioned against the risky festival lying ahead.
-
Looking Very Deeply Into Issue Of Vaccine Booster Dose: NITI Aayog Member
The national expert committee on COVID-19 vaccination has discussed the issue of giving booster vaccine dose and it is being looked into very deeply, NITI Aayog Member (Health) Dr VK Paul said on Tuesday.
-
Serosurvey Does Not Cover Granularity At State Level: NITI Aayog Member
Serosurveys cannot be extrapolated to estimate mortality rates of COVID-19 or undercounting of the number of coronavirus infections as they are not meant to cover granularity at the level of the state, NITI Aayog member (health) Dr VK Paul has said.
-
"Be Watchful, Next 3 Months Important": NITI Aayog Member's Advice To Delhi
Niti Aayog member V K Paul has told the Delhi government to remain watchful as the next three months are important and unlocking activities can lead to an increase in coronavirus cases.
-
India Has Been Offered 7.5 Million Doses Of Moderna COVID-19 Vaccine Through COVAX: WHO
The Government of India is holding discussions with COVID-19 manufacturers Moderna and Pfizer over several issues including indemnity waiver, Dr VK Paul, Member (Health), NITI Aayog said on Friday.
-
Second Wave Not Over, No One Safe Till Entire Country Is Safe: NITI Aayog Member
VK Paul said that the second wave of COVID-19 is not over yet even though India is seeing a decline in the number of fresh cases.
-
"In A Marathon, Not A 100-Metre Sprinter": Centre On Covid Vaccination
India is vaccinating, on average, 50 lakh individuals against Covid daily since June 21, the Centre said today. The number has increased since the drive's new phase phase kicked in on June 21, said Dr VK Paul, NITI Aayog member for health.
-
Pfizer In "Final Stages" Of Approval For Covid Vaccine In India: CEO
Pfizer CEO Albert Bourla has said that his company hope to finalise a deal with the Indian government on the approval for the company's Covid vaccine. A few days ago, NITI Aayog member D VK Paul, too, had said the same thing.
-
Manufacturers To Decide Price Of Covid Vaccines To Private Sectors: Niti Aayog
The price of COVID-19 vaccines to private sectors (hospitals) will be decided by vaccine manufacturers, informed Member (health) NITI Aayog Dr VK Paul on Tuesday.
-
India Overtakes US, Has More Number Of People With 1st Dose Of Vaccine
Member Health NITI Aayog Dr VK Paul on Friday said India has overtaken the United States in terms of the number of people who have received the first dose of COVID-19 vaccine.
-
Pfizer's Indemnity Request Being Examined, Supply Likely In July: Centre
The government is examining Pfizer's request for indemnity and will take a decision in the larger interest of people and on merit, NITI Aayog Member (Health) VK Paul said today.
-
Must Prepare To Administer One Crore Vaccine Doses Per Day: NITI Aayog
India should prepare to administer one crore Covid jabs a day which will be possible in a few weeks with due preparation and the vaccination should be taken up to 73 lakh doses in the next three weeks, Niti Aayog Member (Health) Dr VK Paul said.
